Group One Trading
PHAT icon

Group One Trading’s Phathom Pharmaceuticals PHAT Stock Holding History

Group One Trading’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Sell
16,939
-86,745
-84% -$1.1M ﹤0.01% 4157
2025
Q4 		$1.72M Buy
103,684
+99,436
+2,341% +$1.42M ﹤0.01% 2406
2025
Q3 		$50K Buy
+4,248
New +$43.8K ﹤0.01% 5964
2025
Q2 		– Sell
-2,404
Closed -$13.3K – 8491
2025
Q1 		$15.1K Buy
+2,404
New +$14.6K ﹤0.01% 6004
2024
Q4 		– Sell
-15,130
Closed -$187K – 7804
2024
Q3 		$274K Buy
15,130
+7,762
+105% +$108K ﹤0.01% 3345
2024
Q2 		$75.9K Buy
+7,368
New +$75.9K ﹤0.01% 4180
2024
Q1 		– Sell
-1,545
Closed -$13.1K – 7755
2023
Q4 		$14.1K Buy
+1,545
New +$13.3K ﹤0.01% 5980

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return